Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Minerva Pediatr (Torino) ; 75(4): 598-603, 2023 08.
Article in English | MEDLINE | ID: mdl-31264392

ABSTRACT

INTRODUCTION: The aim of this study was to evaluate whether sepsis and bronchopulmonary dysplasia (BPD) are risk factors for parenteral nutrition-associated cholestasis (PNAC) and to provide suggestions for the prevention of PNAC in infants. EVIDENCE ACQUISITION: Electronic databases (PubMed, EBSCO, Elsevier, Springer, Wiley, and Cochrane) were searched for studies published up to October 22, 2017. Associations between sepsis, BPD and PNAC were assessed using odds ratios (ORs) and 95% confidence intervals (CIs). Heterogeneity was assessed using the I2 statistic, and subgroup analyses were performed. EVIDENCE SYNTHESIS: Nine studies incorporating a total of 2248 cases were included in the meta-analysis. Sepsis was significantly associated with PNAC (pooled OR=2.04; 95% CI: 1.23-2.85), but BPD was not (pooled OR=1.22; 95% CI: 0.65-1.78). In a subgroup analysis, BPD was not associated with PNAC in either the non-Asian group (pooled OR=1.38; 95% CI: 0.58-2.18) or the Asian group (pooled OR=1.05; 95% CI: 0.26-1.84). CONCLUSIONS: Sepsis, but not BPD, was a risk factor for PNAC in this meta-analysis. Further studies are needed to confirm the findings.


Subject(s)
Bronchopulmonary Dysplasia , Cholestasis , Sepsis , Infant, Newborn , Infant , Humans , Retrospective Studies , Bronchopulmonary Dysplasia/complications , Parenteral Nutrition/adverse effects , Cholestasis/complications , Cholestasis/prevention & control , Sepsis/complications , Risk Factors
2.
Zhongguo Dang Dai Er Ke Za Zhi ; 23(8): 809-813, 2021 Aug 15.
Article in English, Chinese | MEDLINE | ID: mdl-34511170

ABSTRACT

OBJECTIVES: To evaluate the accuracy and safety of measurements of transcutaneous carbon dioxide partial pressure (TcPCO2) and transcutaneous oxygen partial pressure (TcPO2) at electrode temperatures lower than the value used in clinical practice in very low birth weight infants. METHODS: A total of 45 very low birth weight infants were enrolled. TcPCO2 and TcPO2 measurements were performed in these infants. Two transcutaneous monitors were placed simultaneously for each subject. One electrode was set and maintained at 42℃ used in clinical practice for neonates (control group), and the other was successively set at 38℃, 39℃, 40°C, and 41℃ (experimental group). The paired t-test was used to compare the measurement results between the groups. A Pearson correlation analysis was used to analyze the correlation between the measurement results of the experimental group and control group, and between the measurement results of experimental group and arterial blood gas parameters. RESULTS: There was no significant difference in TcPCO2 between each experimental subgroup (38-41℃) and the control group. TcPCO2 in each experimental subgroup (38-41℃) was strongly positively correlated with TcPCO2 in the control group (r>0.9, P<0.05) and arterial carbon dioxide partial pressure (r>0.8, P<0.05). There were significant differences in TcPO2 between each experimental subgroup (38-41℃) and the control group (P<0.05), but TcPO2 in each experimental subgroup (38-41℃) was positively correlated with TcPO2 in the control group (r=0.493-0.574, P<0.05) and arterial oxygen partial pressure (r=0.324-0.399, P<0.05). No skin injury occurred during transcutaneous measurements at all electrode temperatures. CONCLUSIONS: Lower electrode temperatures (38-41℃) can accurately measure blood carbon dioxide partial pressure in very low birth weight infants, and thus can be used to replace the electrode temperature of 42°C. Transcutaneous measurements at the lower electrode temperatures may be helpful for understanding the changing trend of blood oxygen partial pressure.


Subject(s)
Blood Gas Monitoring, Transcutaneous , Carbon Dioxide , Electrodes , Humans , Infant , Infant, Newborn , Infant, Very Low Birth Weight , Oxygen , Partial Pressure , Temperature
3.
Indian J Pediatr ; 85(10): 855-860, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29368111

ABSTRACT

OBJECTIVE: To summarize the available randomized controlled trials (RCTs) to evaluate the effect of taurine supplementation on growth in low birth weight infants (LBW). METHODS: PubMed, EmBase, and Cochrane Library electronic databases were searched for published articles through March 2017. Analysis was done to examine the effect of taurine supplementation on growth, and sensitivity analysis was performed by removing each individual study from meta-analysis. RESULTS: Results of 9 trials totaling 216 LBW infants in the present meta-analysis were collected and analyzed. The conclusion of included studies demonstrated that taurine supplementation significantly reduced length gain (WMD:-0.18; P < 0.001), plasma glycine (WMD:-106.71; P = 0.033), alanine (WMD:-229.30; P = 0.002), leucine (WMD:-64.76; P < 0.001), tyrosine (WMD:-118.11; P < 0.001), histidine (WMD:-52.16; P < 0.001), proline (WMD: -84.29; P = 0.033), and asparagine-glutamine (WMD:-356.30; P < 0.001). However, taurine supplementation was associated with higher levels of acidic sterols (WMD:0.61; P = 0.024), total fatty acids (WMD:7.94; P = 0.050), total saturated fatty acids (WMD:9.70; P < 0.001), and unsaturated fatty acids (WMD:6.63; P < 0.001). Finally, taurine supplementation had little or no significant effect on weight gain, head circumference gain, plasma taurine, threonine, serine, citrulline, valine, methionine, isoleucine, phenylalanine, ornithine, lysine, arginine, glutamate, hydroxyproline, aspartate, dietary cholesterol, endogenous neutral sterols, cholesterol synthesis, and medium-chain triglycerides. CONCLUSIONS: The findings suggest that although there are several significant differences in plasma indeces, no significant effect on growth in LBW infants was observed with taurine supplementation.


Subject(s)
Food, Fortified , Infant Formula , Infant, Low Birth Weight/growth & development , Taurine/therapeutic use , Body Height , Cephalometry , Humans , Infant, Low Birth Weight/blood , Infant, Newborn , Weight Gain
4.
Mater Sci Eng C Mater Biol Appl ; 33(3): 1085-90, 2013 Apr 01.
Article in English | MEDLINE | ID: mdl-23827546

ABSTRACT

In this study, porous Ti-10Mo alloy was prepared from a mixture of titanium, molybdenum and epoxy resin powders by selective laser sintering preforming, debinding and sintering at 1200 °C under a pure argon atmosphere. The influence of sintering process on the porous, microstructural and mechanical properties of the porous alloy was discussed. The results indicate that the pore characteristic parameters and mechanical properties mainly depend on the holding time at 1200 °C, except that the maximum strain keeps at about 45%. The matrix microstructure is dominated by α phase with a small quantity of ß phase at room temperature. As the holding time lengthens from 2 to 6h, the average pore size and the porosity decrease from 180 to 50 µm and from 70 to 40%, respectively. Meanwhile, the Young's modulus and the compressive yield strength increase in the ranges of 10-20 GPa and 180-260 MPa, respectively. Both the porous structure and the mechanical properties of the porous Ti-10Mo alloy can be adjusted to match with those of natural bone.


Subject(s)
Alloys/chemistry , Alloys/chemical synthesis , Lasers , Materials Testing , Calorimetry, Differential Scanning , Compressive Strength , Microscopy, Electron, Scanning , Molybdenum/chemistry , Porosity , Powders , Thermogravimetry , Titanium/chemistry , X-Ray Diffraction
SELECTION OF CITATIONS
SEARCH DETAIL
...